Hot Life Science Investor Mandate 1: Family Office Seeking Preclinical Therapeutics

6 Feb

A family office based in the Central United States is looking to make equity investments into companies ranging from $.5 – $5 million with a preference for the middle of that range. The firm is also willing to co-invest with investors they either know well or are able to get a strong reference for.  The firm looks to invest in seed and series A rounds and looks to take a significant stake in the company’s equity.  The firm prefers to invest in companies that are not located in an areas highly saturated with venture capital. The firm plans to make 3-4 new investments over the next 12 months.

The family office is currently seeking companies in the therapeutics space and is open to both small molecules and biologics. The firm is looking for companies with pre-clinical assets that have some animal data and will also consider companies in early clinical trials if the valuation is appropriate. The firm is open to review all indications and currently is working with companies in the neurology and antibiotics space. The firm would also consider investments in companies developing high tech medical devices and diagnostics with a special interest in companies that are bridging the gap between Biology and Software. The firm is not interested in investing in drug discovery platforms.

The family office is looking for companies founded by passionate entrepreneurs pursuing novel science.   The firm takes an active investor role and generally looks to take a board seat following investment. The firm is a value-added investor, including providing virtual management team services to support our portfolio companies that don’t have a full team on board.  The firm is looking for companies with pre-money valuations under $5 million, with a special interest in opportunities valued under $2 million.

5 Responses to “Hot Life Science Investor Mandate 1: Family Office Seeking Preclinical Therapeutics”

  1. Richard Maisto February 8, 2014 at 8:45 pm #

    I have a very good opportunity for this family office.

  2. Laurence Briggs March 20, 2014 at 2:56 pm #

    I am interested in meeting this company for a medical device for the intimate women’s health market. An NDA will be required before fulldisclosure

  3. David Owens March 20, 2014 at 4:05 pm #

    I have an investment opportunity for a preclinical therapeutics company that is starting to receive composition of matter patents and has strong differentiating features that make it very attractive as a future therapeutic. Would you be interested in knowing more?

  4. Vincent Renz March 21, 2014 at 1:42 am #

    i have an investment opportunity in a for a preclinical therapeutics company, with strong IP, that is developing a platform technology that is addressing unmet needs, utilizes a novel approach, has the potential to be in the clinic within 2 years, and could potentially be considered for orphan status. Please let me know if would like to know more about this opportunity.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: